PGNX - Progenics Pharmaceuticals Inc.

Industry: Biotechnology Sector: Healthcare

Sell Candidate
Wed 26'th Apr 2017

PERIOD COVERED
2017-01-27 - 2017-04-26
CHANGE
-0.13%
PRICE
$7.88
VOLUME
Buy
TREND
Sell
MV LONG
Sell
MV SHORT
Sell
PIVOT
Sell
MACD
Buy
Request Prediction
0.00%
We need your help. Please answer this short survey to help us improve by clicking HERE.

Progenics Pharmaceuticals Inc. Stock Analysis

Technical stock analysis for Wed 26'th Apr 2017

Sell candidate since 2017-04-26

Progenics Pharmaceuticals Inc. fell by -0.13% in the last day, from USD 7.89 to USD 7.88 The price has been going up and down for this period, and there has been a -3.55% loss for the last 2 weeks. Volume has increased in the last day by 0.21 million shares, but on falling prices. This is may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.28 million shares bought and sold for approximately USD 10.11 million.

Trend

Progenics Pharmaceuticals Inc. lies in the lower of a very wide and strong falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at USD 7.65 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -12.4% during the next 3 months and, with 90% probability hold a price between USD 6.70 and USD 9.52 at the end of this period.

Signals

There are few to none technical positive signals at the moment. Progenics Pharmaceuticals Inc. holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at USD 7.98 and USD 9.66. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday April 25, 2017, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Relative Strength Index (RSI)

RSI14 is 30 and the stock is currently not being overbought or oversold

Support & Resistance

Progenics Pharmaceuticals Inc. finds support from accumulated volume at USD 7.75, USD 7.70. On the upside the stock meets some resistance from accumulated volume at USD 9.60, USD 9.67 and USD 9.62.

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved USD 0.29 between high and low, or 3.70%. For the last week, the stock has had a daily average volatility of 4.85%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Evaluation

Progenics Pharmaceuticals Inc. holds several negative signals and is within a very wide and strong falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.

Sell Candidate

Learn To Identify Profitable Stock Chart Patterns.

FREE 7-Day Training

Learn To Identify Profitable Stock Chart Patterns.

FREE 7-Day Training

Build Your Watchlist

Add PGNX My Watchlist

Recommended
book of the week